KAREN CLUM: Open Payments
NPI 1538576244 · WESTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 40 payments from 15 companies in 2025. Trend: 2023 $852 · 2024 $693 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $196 |
| Otsuka America Pharmaceutical, Inc. | 3 | $146 |
| Alkermes, Inc. | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Tris Pharma Inc | 1 | $23 |
Products named: VRAYLAR, REXULTI, Qelbree, CAPLYTA, ARISTADA, FANAPT, Auvelity, SPRAVATO.
Industry payments across OH — which companies pay providers there.
